Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3765070012 | Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3765071011 | Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4628681000052114 | natriumsulfacetamid 28,6 milligram/milliliter, sulfabensamid 37 milligram/milliliter och sulfatiazol 34,2 milligram/milliliter, vaginalkräm | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has precise active ingredient | Sulfathiazole (substance) | true | Inferred relationship | Some | 3 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 2 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has basis of strength substance (attribute) | Sulfathiazole (substance) | true | Inferred relationship | Some | 3 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 3 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | räkning av bas i aktiv ingrediens | tre | false | Inferred relationship | Some | ||
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has manufactured dose form | Vaginal cream | true | Inferred relationship | Some | ||
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 3 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | har täljarvärde för koncentrationsstyrka | 34,2 | false | Inferred relationship | Some | 3 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Is a | Sulfabenzamide and sulfacetamide and sulfathiazole only product in vaginal dose form | true | Inferred relationship | Some | ||
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | har täljarvärde för koncentrationsstyrka | 37 | false | Inferred relationship | Some | 2 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has precise active ingredient | Sulfabenzamide (substance) | true | Inferred relationship | Some | 2 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has basis of strength substance (attribute) | Sulfacetamide sodium | true | Inferred relationship | Some | 1 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has precise active ingredient | Sulfacetamide sodium | true | Inferred relationship | Some | 1 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Has basis of strength substance (attribute) | Sulfabenzamide (substance) | true | Inferred relationship | Some | 2 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | har täljarvärde för koncentrationsstyrka | 28,6 | false | Inferred relationship | Some | 1 | |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets